Login
Companies $SLS
$7.41 -$0.06 (0.84%) After hours
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

sellaslifesciences.com

What Do They Do?

Develops experimental cancer therapies for people with blood cancers and solid tumors.

Who Are Their Customers?

SELLAS licenses GPS and GPS Plus directly to 3D Medicines for development, manufacturing and commercialization in Greater China; it retained rights outside that territory.

Who Do They Compete With?

Competes with AbbVie, Genentech, Pfizer, Daiichi-Sankyo, Rigel Pharmaceuticals, Syndax Pharmaceuticals, Bristol Myers Squibb, Curis, Delta-Fly Pharma, AROG Pharmaceuticals, Sumitomo Dainippon Pharma, Cothera Bioscience, and Prelude Therapeutics

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support